Cui Xiaoshan, Li Yinglan, Zhao Tongxiu
Department of General Medicine, the People's Hospital of Qinghai Province, Xining 810000, China.
Department of General Medicine, the People's Hospital of Qinghai Province, Xining 810000, China. *Corresponding author, E-mail:
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2025 Jul;41(7):637-643.
Objectives To investigate interleukin 36γ (IL-36γ) expression, and analyze the influence of IL-36γ to CD8 T cell activity in chronic obstructive pulmonary diseases (COPD) patients with secondary fungal pneumonia. Methods Peripheral blood was collected from 47 COPD patients, 39 COPD patients with secondary fungal pneumonia, and 20 controls. Bronchial alveolar lavage fluid (BALF) was isolated from 27 COPD patients with secondary fungal pneumonia. CD8 T cells were purified. The levels of four IL-36 isoforms in plasma and BALF were measured by enzyme linked immunosorbent assay (ELISA). CD8 T cells were stimulated with recombinant human IL-36γ. The levels of interferon γ(IFN-γ), tumor necrosis factor α(TNF-α), perforin and granzyme B in the cultured supernatants were measured by ELISA. Recombinant human IL-36γ-stimulated CD8 T cells were co-cultured with NCI-H1882 cells in either direct cell-to-cell contact or Transwell manner. The levels of IFN-γ, TNF-α, and lactate dehydrogenase in the cultured supernatants were assessed. The percentage of target cell death was calculated. Results Plasma IL-36α, IL-36β, and IL-36γ levels were significantly elevated in both COPD group and COPD with secondary fungal pneumonia group compared with those in control group. However, only plasma IL-36γ level was higher in COPD with secondary fungal pneumonia group than that in COPD group [(200.11±99.95)pg/mL vs (53.03±87.18)pg/mL, P=0.023]. There was no remarkable difference in plasma IL-36 receptor antagonist level among three groups. IL-36γ level in BALF from infectious site was higher than that from non-infectious site in COPD with secondary fungal pneumonia group [(305.82±59.60)pg/mL vs (251.93±76.01)pg/mL, P=0.011]. IL-36γ stimulation enhanced IFN-γ, TNF-α, perforin and granzyme B secreted by CD8 T cells. When IL-36γ-stimulated CD8 T cells were directly mixed with NCI-H1882 cells for co-culture, the percentage of cell death was increased [(16.06±3.67)% vs (11.47±2.36)%, P=0.002]. When using Transwell plate for non-contact co-culture, IL-36γ-stimulated CD8 T cell-mediated death of NCI-H1882 cells showed no significant difference compared to that without stimulation [(4.77±0.78)% vs (4.99±0.92)%, P=0.554]. Conclusion IL-36γ level in plasma and infectious site is elevated in COPD patients with secondary fungal pneumonia, which enhances the cytotoxicity of CD8 T cells in peripheral blood and infectious microenviroment.
目的 探讨白细胞介素36γ(IL-36γ)的表达情况,并分析IL-36γ对慢性阻塞性肺疾病(COPD)合并继发性真菌性肺炎患者CD8 T细胞活性的影响。方法 收集47例COPD患者、39例COPD合并继发性真菌性肺炎患者及20例对照者的外周血。从27例COPD合并继发性真菌性肺炎患者中分离支气管肺泡灌洗液(BALF)。纯化CD8 T细胞。采用酶联免疫吸附测定(ELISA)法检测血浆和BALF中4种IL-36亚型的水平。用重组人IL-36γ刺激CD8 T细胞。采用ELISA法检测培养上清液中干扰素γ(IFN-γ)、肿瘤坏死因子α(TNF-α)、穿孔素和颗粒酶B的水平。将重组人IL-36γ刺激的CD8 T细胞与NCI-H1882细胞以直接细胞接触或Transwell方式共培养。评估培养上清液中IFN-γ、TNF-α和乳酸脱氢酶的水平。计算靶细胞死亡百分比。结果 与对照组相比,COPD组和COPD合并继发性真菌性肺炎组血浆IL-36α、IL-36β和IL-36γ水平均显著升高。然而,COPD合并继发性真菌性肺炎组血浆IL-36γ水平高于COPD组[(200.11±99.95)pg/mL对(53.03±87.18)pg/mL,P=0.023]。三组血浆IL-36受体拮抗剂水平无显著差异。COPD合并继发性真菌性肺炎组感染部位BALF中IL-36γ水平高于非感染部位[(305.82±59.60)pg/mL对(251.93±76.01)pg/mL,P=0.011]。IL-36γ刺激增强了CD8 T细胞分泌的IFN-γ、TNF-α、穿孔素和颗粒酶B。当IL-36γ刺激的CD8 T细胞与NCI-H1882细胞直接混合共培养时,细胞死亡百分比增加[(16.06±3.67)%对(11.47±2.36)%,P=